Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API bulk drug products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, triciabendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, halquinol, and 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.
Key Metrics
as of Sep 2026
Market Cap 34 Cr
P/E โ
Div Yield 0.00 %
Book Value โน9.90
52w High โน14.10
52w Low โน5.65
Face Value โน10.00
Quarterly Results
Rs. Crores ยท hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
1.23
-0.13
2.20
3.06
20.01
39.14
33.08
39.39
30.84
22.82
26.66
24.30
30.56
Expenses
2.62
1.99
2.95
7.06
20.51
35.73
32.81
38.60
29.04
26.81
25.60
23.25
26.51
Operating Profit
-1.39
-2.12
-0.75
-4.00
-0.50
3.41
0.27
0.79
1.80
-3.99
1.06
1.05
4.05
OPM %
-113.01
โ
-34.09
-130.72
-2.50
8.71
0.82
2.01
5.84
-17.48
3.98
4.32
13.25
Other Income
-0.38
-0.42
0.02
0.01
-20.44
-21.52
8.91
1.95
0.00
-8.76
0.00
0.08
0.00
Depreciation
1.57
1.31
1.57
1.57
1.57
3.90
2.80
2.81
2.79
2.66
2.68
2.68
2.65
Interest
0.14
0.13
0.11
0.12
0.03
0.11
0.47
1.24
0.87
0.56
0.44
0.56
0.37
Profit before tax
-3.48
-3.98
-2.41
-5.68
-22.54
-22.12
5.91
-1.31
-1.86
-15.97
-2.06
-2.11
1.03
Tax %
3.16
4.77
5.81
10.04
-6.30
-35.40
7.11
146.56
46.77
-4.20
-29.61
-99.05
580.58
Net Profit
-3.58
-4.16
-2.55
-6.25
-21.12
-14.29
5.49
-3.23
-2.73
-15.30
-1.46
-0.02
-4.95
EPS in Rs
-0.71
-0.83
-0.51
-1.25
-4.22
-2.85
1.10
-0.64
-0.54
-3.05
-0.29
0.00
-0.99
Profit & Loss
Annual ยท Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016
Sales
25.00 142.00 104.00 130.00 137.00 201.00 167.00 170.00 244.00 199.00 0.00
Expenses
32.00 136.00 102.00 136.00 120.00 154.00 137.00 158.00 202.00 153.00 0.00
Operating Profit
-7.00 6.00 2.00 -6.00 16.00 47.00 30.00 11.00 41.00 46.00 0.00
OPM %
-29.00 4.40 2.10 -4.90 12.00 24.00 18.00 7.00 17.00 23.00 โ
Other Income
-21.00 -11.00 -9.00 -18.00 -8.00 0.00 0.00 0.00 3.00 -24.00 0.00
Interest
0.00 3.00 2.00 4.00 0.00 2.00 8.00 8.00 11.00 12.00 0.00
Depreciation
6.00 12.00 11.00 13.00 15.00 16.00 17.00 19.00 18.00 8.00 0.00
Profit before tax
-35.00 -19.00 -19.00 -42.00 -6.00 30.00 5.00 -16.00 15.00 2.00 0.00
Tax %
-2.00 -24.00 14.00 -9.00 -13.00 23.00 23.00 -25.00 19.00 -10.00 โ
Net Profit
-34.00 -15.00 -22.00 -39.00 -5.00 23.00 4.00 -12.00 12.00 2.00 0.00
EPS in Rs
-6.80 -2.95 -4.34 -7.71 -1.31 5.60 0.89 -5.26 5.40 โ โ
Dividend Payout %
0.00 0.00 0.00 0.00 -24.00 4.00 0.00 0.00 0.00 0.00 โ
Balance Sheet
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016
Equity Capital
50.00 50.00 50.00 50.00 50.00 41.00 41.00 23.00 23.00 0.05 0.05
Reserves
0.00 34.00 47.00 68.00 108.00 118.00 101.00 82.00 94.00 75.00 0.00
Borrowings
10.00 2.00 22.00 22.00 20.00 19.00 48.00 85.00 107.00 116.00 0.00
Other Liabilities
7.00 16.00 32.00 24.00 31.00 29.00 42.00 69.00 63.00 37.00 0.00
Total Liabilities
66.00 102.00 151.00 164.00 209.00 208.00 232.00 258.00 287.00 228.00 0.00
Fixed Assets
55.00 68.00 110.00 119.00 137.00 143.00 152.00 162.00 170.00 119.00 0.00
CWIP
0.00 0.00 3.00 5.00 5.00 0.00 0.00 7.00 7.00 30.00 0.00
Investments
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
11.00 33.00 39.00 40.00 67.00 65.00 80.00 90.00 110.00 80.00 0.00
Total Assets
66.00 102.00 151.00 164.00 209.00 208.00 232.00 258.00 287.00 228.00 0.00
Cash Flows
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016
Cash from Operating Activity
0.00 -3.00 2.00 -17.00 9.00 41.00 14.00 41.00 40.00 -3.00 0.00
Cash from Investing Activity
0.00 8.00 0.00 11.00 -3.00 -4.00 -2.00 -7.00 -44.00 0.00 0.00
Cash from Financing Activity
0.00 -6.00 -2.00 -4.00 0.00 -36.00 -10.00 -33.00 4.00 0.00 0.00
Net Cash Flow
0.00 0.00 0.00 -10.00 6.00 1.00 2.00 0.00 0.00 -3.00 0.00
Free Cash Flow
0.00 5.00 0.00 -12.00 12.00 35.00 13.00 29.00 -6.00 -5.00 0.00
CFO/OP %
1.00 -45.00 96.00 273.00 73.00 87.00 46.00 397.00 103.00 -6.00 โ
Ratios
Annual ยท Days / % โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017
Debtor Days
1.00 4.00 13.00 7.00 50.00 27.00 45.00 62.00 63.00 64.00
Inventory Days
28.00 84.00 92.00 48.00 46.00 56.00 101.00 90.00 90.00 93.00
Days Payable
32.00 35.00 68.00 32.00 68.00 41.00 130.00 170.00 102.00 71.00
Cash Conversion Cycle
-4.00 53.00 37.00 22.00 28.00 42.00 16.00 -18.00 51.00 87.00
Working Capital Days
-102.00 37.00 -44.00 -17.00 12.00 35.00 -13.00 -52.00 -1.00 15.00
ROCE %
-18.00 -1.00 -6.00 -12.00 1.00 17.00 7.00 -4.00 13.00 42.00
Shareholding Pattern
% holding โ latest first
Quarterly
Yearly
Holder
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Promoters
53.65
53.65
53.65
53.65
53.65
53.65
53.65
53.65
53.65
53.65
53.65
53.65
FIIs
0.00
0.00
0.00
0.47
0.00
0.00
0.01
0.00
0.12
0.01
0.00
0.00
Public
46.35
46.34
46.35
45.88
46.35
46.35
46.32
46.34
46.23
46.33
46.34
46.34
No. of Shareholders
27,702
28,120
28,656
28,115
27,188
27,272
27,968
27,217
27,615
27,161
27,770
28,031
Corporate Actions
7 records
Back to all stocks